CD8A and neoplasm: Indeed, studies performed in patients and in mice with advanced melanoma showed that blockade of both PD-1 and Tim-3 acts synergistically to enhance TA-specific CD8+ T cell numbers and functions, resulting in decreased tumor growth (82–84).